InMode Ltd. (INMD)
INMD Stock Price Chart
Explore InMode Ltd. interactive price chart. Choose custom timeframes to analyze INMD price movements and trends.
INMD Company Profile
Discover essential business fundamentals and corporate details for InMode Ltd. (INMD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
8 Aug 2019
Employees
599.00
Website
https://www.inmodemd.comCEO
Moshe Mizrahy
Description
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
INMD Financial Timeline
Browse a chronological timeline of InMode Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 2 Feb 2026
Upcoming earnings on 29 Oct 2025
EPS estimate is $0.32, while revenue estimate is $88.05M.
Earnings released on 30 Jul 2025
EPS came in at $0.47 surpassing the estimated $0.43 by +9.30%, while revenue for the quarter reached $95.60M , missing expectations by -2.89%.
Earnings released on 28 Apr 2025
EPS came in at $0.31 falling short of the estimated $0.33 by -6.06%, while revenue for the quarter reached $77.87M , missing expectations by -20.90%.
Earnings released on 4 Feb 2025
EPS came in at $0.42 falling short of the estimated $0.50 by -16.00%, while revenue for the quarter reached $97.85M , missing expectations by -6.81%.
Earnings released on 30 Oct 2024
EPS came in at $0.70 surpassing the estimated $0.63 by +11.11%, while revenue for the quarter reached $130.23M , beating expectations by +13.46%.
Earnings released on 1 Aug 2024
EPS came in at $0.34 falling short of the estimated $0.38 by -10.53%, while revenue for the quarter reached $86.45M , missing expectations by -14.97%.
Earnings released on 2 May 2024
EPS came in at $0.32 falling short of the estimated $0.41 by -21.95%, while revenue for the quarter reached $80.28M , missing expectations by -10.28%.
Earnings released on 13 Feb 2024
EPS came in at $0.71 surpassing the estimated $0.67 by +5.97%, while revenue for the quarter reached $126.78M , beating expectations by +1.39%.
Earnings released on 2 Nov 2023
EPS came in at $0.61 falling short of the estimated $0.64 by -4.69%, while revenue for the quarter reached $123.11M , missing expectations by -6.92%.
Earnings released on 27 Jul 2023
EPS came in at $0.72 surpassing the estimated $0.64 by +12.50%, while revenue for the quarter reached $136.08M , beating expectations by +3.09%.
Earnings released on 2 May 2023
EPS came in at $0.52 surpassing the estimated $0.47 by +10.64%, while revenue for the quarter reached $106.07M , beating expectations by +4.72%.
Earnings released on 14 Feb 2023
EPS came in at $0.78 surpassing the estimated $0.74 by +5.41%, while revenue for the quarter reached $133.57M , beating expectations by +2.99%.
Earnings released on 27 Oct 2022
EPS came in at $0.66 surpassing the estimated $0.58 by +13.79%, while revenue for the quarter reached $121.23M , beating expectations by +6.79%.
Earnings released on 28 Jul 2022
EPS came in at $0.59 surpassing the estimated $0.51 by +15.69%, while revenue for the quarter reached $113.55M , beating expectations by +10.08%.
Earnings released on 2 May 2022
EPS came in at $0.40 surpassing the estimated $0.38 by +5.26%, while revenue for the quarter reached $85.92M , beating expectations by +7.10%.
Earnings released on 10 Feb 2022
EPS came in at $0.64 surpassing the estimated $0.56 by +14.29%, while revenue for the quarter reached $110.54M , beating expectations by +5.29%.
Earnings released on 26 Oct 2021
EPS came in at $0.55 surpassing the estimated $0.50 by +10.00%, while revenue for the quarter reached $94.18M , beating expectations by +27.16%.
Stock split effective on 1 Oct 2021
Shares were split 2 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Jul 2021
EPS came in at $0.51 surpassing the estimated $0.43 by +18.60%, while revenue for the quarter reached $87.33M , beating expectations by +17.91%.
Earnings released on 5 May 2021
EPS came in at $0.35 surpassing the estimated $0.27 by +29.63%, while revenue for the quarter reached $65.52M , beating expectations by +43.24%.
Earnings released on 10 Feb 2021
EPS came in at $0.47 surpassing the estimated $0.38 by +23.68%, while revenue for the quarter reached $75.19M , beating expectations by +31.03%.
Earnings released on 12 Nov 2020
EPS came in at $0.32 surpassing the estimated $0.24 by +33.33%, while revenue for the quarter reached $59.71M , beating expectations by +45.45%.
INMD Stock Performance
Access detailed INMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.